News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


MSNZ welcomes consultation period for Tysabri and Gilenya

Media release (8 August 2014)


MSNZ welcomes beginning of consultation period for Tysabri and Gilenya as proposed new first-line treatments for relapsing remitting forms of Multiple Sclerosis.

The Multiple Sclerosis Society of New Zealand (MSNZ) welcomes PHARMAC’s release of a consultation document today that proposes Natalizumab (Tysabri)and Fingolimod (Gilenya) as potential new first-line treatments for relapsing, remitting forms of MS.

PHARMAC is seeking feedback on a funding proposal involving five treatments for multiple sclerosis (MS), including these two new treatments. It is also seeking feedback on potential changes to the currently funded treatments Avonex, Betaferon and Copaxone.

In February, PTAC (the Pharmaceutical Technical Advisory Committee) recommended to PHARMAC that these new treatments be funded as new first-line treatments.

“It has been a long process to get to this point but PHARMAC’s announcement is a positive step,” says MSNZ spokesman Neil Woodhams. “Relapsing Remitting MS is one of four types of MS, affecting the highest percentage of patients. These new treatments, if accepted by PHARMAC, will be given as soon after diagnosis as possible, to patients fitting within the criteria. This is a great start for all those who will benefit from these treatments.”

Subject to a positive outcome from its consultation process, PHARMAC has suggested that Natalizumab and Fingolimod could be listed on the Hospital Medications List by 1 November 2014 and that changes to the restrictions around access to treatments that are currently funded could also be made by that date.

“This is not the end of the process,” says Mr Woodhams. “The next stage of consultation begins today. We recommend that interested parties read the consultation documents carefully as there are restrictions on the access to these treatments and changes that will be made to the currently-funded treatments.”

Submissions on PHARMAC’s consultation document close on 29 August, 2014.

“MSNZ would like to thank everyone involved in the Patients’ Steering Group, the MS Community, neurologists and supporters who have helped to highlight the importance of funding these new first-line treatments. MSNZ has been overwhelmed with the support and commitment shown to date and we urge supporters to maintain their level of engagement during the next stage of the process and beyond.”


More information about the consultation documents:
For more information visit the PHARMAC website:
www.pharmac.health.nz/news/consultation-2014-08-07-mstreatments/

Details of the proposal, including proposed funding access criteria, and some background information can be found at:
www.pharmac.health.nz/assets/consultation-2014-08-07-mstreatments.pdf

Please note: The fingolimod component of this proposal is dependent on a multi-product provisional agreement with Novartis, for a number of other products including fingolimod, being approved. PHARMAC are consulting on the Novartis multiproduct proposal separately, see PHARMAC’s website at: www.pharmac.health.nz/news/consultation-2014-08-07-multiproduct.
www.pharmac.health.nz/assets/consultation-2014-08-07-multiproduct.pdf

About MSNZ:
For more information about MSNZ please email info@msnz.org.nz or call 0800 MS LINE (67 54 63).

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Culture: Rare Hundertwasser Conservation Posters Found After 40 Years

When Jan and Arnold Heine put a roll of conservation posters into storage in 1974 they had no idea that 42 years later they would be collectors items. More>>

Scoop Review Of Books: The Stolen Island: Searching for ‘Ata by Scott Hamilton

Reviewed by Michael Horowitz
Located even further south than temperate Noumea, Tonga’s tiny island of ‘Ata might have become the jewel of the kingdom’s burgeoning tourist industry. Imagine a Tongan resort that would not only be mild in winter, but pleasant in summer. More>>

Reviewed by Michael Horowitz
Located even further south than temperate Noumea, Tonga’s tiny island of ‘Ata might have become the jewel of the kingdom’s burgeoning tourist industry. Imagine a Tongan resort that would not only be mild in winter, but pleasant in summer. More>>

Scoop Review Of Books: No Pretence. No Bullshit. Fine Poem.

John Dickson doesn’t publish much; never has. Indeed, this new collection is his first such in 18 years. As he wryly and dryly states,

I’ve published two slim volumes, and spent all
My time working on the next.
(from Wasp p.67) More>>

Scoop Review of Books: Extraordinary Anywhere: Essays On Place From Aotearoa NZ

The New Zealand landscape undoubtedly is very beautiful, but so is the British one, and my attachment to this country is much more about some particular places, and the memories and emotions that in them combine, than it is about the landscape as a whole. More>>

Canonisation Fodder: Suzanne Aubert Declared ‘Venerable’

Suzanne Aubert, the founder of the Sisters of Compassion New Zealand’s home grown order of Sisters, has been declared ‘venerable’, a major milestone on the path to sainthood in the Catholic Church. More>>

“I Have Not Performed Well Enough”: Ernie Merrick Leaving Wellington Phoenix

Ernie Merrick has stepped down from his position as Wellington Phoenix FC Head Coach. The club would like to thank Ernie for his contribution to Wellington Phoenix and wish him all the best in his future endeavours. More>>

Ray Columbus: NZ Music Icon Passes Away

60s New Zealand music Icon Ray Columbus has passed away peacefully at his home north of Auckland... Ray Columbus enjoyed more than three decades at the top of NZ entertainment as a singer, songwriter, bandleader, music manager and TV star. More>>

Review: Bernard Herrmann's Scores For 'Vertigo' & 'Psycho'

Howard Davis: The NZSO's adventurousness was richly-rewarded, as the deeply appreciative Wellington audience was given the opportunity not only to see a couple of Alfred Hitchcock's greatest films, but also to hear fine renditions of two of Bernard Herrmann's most accomplished film scores. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news